Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Book Value per Share : ¥22.41 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Anhui Wanbang Pharmaceutical Technology Co Book Value per Share?

Anhui Wanbang Pharmaceutical Technology Co's book value per share for the quarter that ended in Mar. 2024 was ¥22.41.

During the past 12 months, Anhui Wanbang Pharmaceutical Technology Co's average Book Value Per Share Growth Rate was 214.10% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 93.70% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 80.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Anhui Wanbang Pharmaceutical Technology Co was 119.10% per year. The lowest was 7.90% per year. And the median was 93.70% per year.

Anhui Wanbang Pharmaceutical Technology Co's current price is ¥45.03. Its book value per share for the quarter that ended in Mar. 2024 was ¥22.41. Hence, today's PB Ratio of Anhui Wanbang Pharmaceutical Technology Co is 2.01.

During the past 6 years, the highest P/B Ratio of Anhui Wanbang Pharmaceutical Technology Co was 12.97. The lowest was 1.90. And the median was 2.46.

Good Sign:

Anhui Wanbang Pharmaceutical Technology Co Ltd stock PB Ratio (=2.05) is close to 1-year low of 1.9

Anhui Wanbang Pharmaceutical Technology Co Book Value per Share Historical Data

The historical data trend for Anhui Wanbang Pharmaceutical Technology Co's Book Value per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Wanbang Pharmaceutical Technology Co Book Value per Share Chart

Anhui Wanbang Pharmaceutical Technology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Book Value per Share

Get a 7-Day Free Trial

5.29

3.02

4.66

6.63

21.96

Anhui Wanbang Pharmaceutical Technology Co Quarterly Data
	Dec18	Dec19	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Book Value per Share	Get a 7-Day Free Trial									7.13	5.78	21.50	21.96	22.41

Competitive Comparison of Anhui Wanbang Pharmaceutical Technology Co's Book Value per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Anhui Wanbang Pharmaceutical Technology Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anhui Wanbang Pharmaceutical Technology Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anhui Wanbang Pharmaceutical Technology Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Anhui Wanbang Pharmaceutical Technology Co's PB Ratio falls into.

Anhui Wanbang Pharmaceutical Technology Co Book Value per Share Calculation

Anhui Wanbang Pharmaceutical Technology Co's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1,464.0	-	0.0)	/	66.7
	=	21.96

Anhui Wanbang Pharmaceutical Technology Co's Book Value Per Share for the quarter that ended in Mar. 2024 is calculated as:

Book Value Per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1,493.7	-	0.0)	/	66.7
	=	22.41

Theoretically it is what the shareholders will receive if the company is liquidated. Total Stockholders Equity is a balance sheet item and equal to Total Assets less Total Liabilities of the company.

Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Book Value per Share Explanation

Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.

For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.

Anhui Wanbang Pharmaceutical Technology Co Book Value per Share Related Terms

Thank you for viewing the detailed overview of Anhui Wanbang Pharmaceutical Technology Co's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anhui Wanbang Pharmaceutical Technology Co Ltd (SZSE:301520) » Definitions » Book Value per Share

Traded in Other Exchanges

N/A

Address

southwest corner of the intersection of Mingzhu Avenue and Huolongdi Road, Building 1, Anhui Wanbang Pharmaceutical, High-tech Zone, Anhui, Hefei, CHN, 230000

Website

http://www.ahwbyy.cn

Anhui Wanbang Pharmaceutical Technology Co Ltd is a one-stop CRO service platform that engages in the entire process from pharmaceutical development to clinical research of innovative drugs, improved new drugs and generic drugs. It aims to provide drug research and development and clinical trials for drug launch, including pharmaceutical research, clinical services, biological sample analysis and testing, SMO services and data statistics and analysis.

Anhui Wanbang Pharmaceutical Technology Co (SZSE:301520) Headlines

No Headlines